Menu Search
Equities

GN Store Nord A/S

GN:CPH

GN Store Nord A/S

Actions
Health CareMedical Equipment and Services
  • Price (DKK)188.05
  • Today's Change9.05 / 5.06%
  • Shares traded524.31k
  • 1 Year change+21.24%
  • Beta1.2093
Data delayed at least 15 minutes, as of Apr 26 2024 16:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-May-23
  • 15-Feb-24
  • 14-Mar-24
  • 18-Apr-24
  • 25-Apr-24
Select bar for recommendation details.
Recommendations25-Apr-24
Buy4
Outperform9
Hold5
Underperform1
Sell0

Share price forecast in DKK

The 17 analysts offering 12 month price targets for GN Store Nord A/S have a median target of 220.00, with a high estimate of 305.00 and a low estimate of 150.00. The median estimate represents a 16.99% increase from the last price of 188.05.
High62.2%305.00
Med17.0%220.00
Low-20.2%150.00

Dividends in DKK

Dividend information is not available for GN Store Nord A/S.
Div growth (TTM)--
More ▼

Earnings history & estimates in DKK

On Feb 08, 2024, GN Store Nord A/S reported 4th quarter 2023 earnings of 0.24 per share.
The next earnings announcement is expected on May 02, 2024.
Average growth rate+225.61%
GN Store Nord A/S reported annual 2023 earnings of 1.64 per share on Feb 08, 2024.
Average growth rate-25.38%
More ▼

Revenue history & estimates in DKK

GN Store Nord A/S had 4th quarter 2023 revenues of 5.07bn. This bettered the 5.02bn consensus of the 6 analysts covering the company. This was 31.36% above the prior year's 4th quarter results.
Average growth rate-0.14%
GN Store Nord A/S had revenues for the full year 2023 of 18.12bn. This was 3.03% below the prior year's results.
Average growth rate+9.92%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.